CompletedPhase 3

Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease

NCT00180037

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Department of Neurology, University of Ulm

Ulm, Baden-Wurttemberg, Germany

+12 additional locations

Save this trial

Department of Neurology, University of UlmUlm, Baden-Wurttemberg, Germany
Department of Neurology, Fachklinik IchenhausenIchenhausen, Bavaria, Germany
Department of Neurology, Leopoldina KrankenhausSchweinfurt, Bavaria, Germany
Department of Neurology, University of MarburgMarburg, Hesse, Germany
Department of Neurology, Deutsche Klinik fuer DiagnostikWiesbaden, Hesse, Germany
Department of Nuerology, Klinikum LippeLemgo, Lower Saxony, Germany
Department of Neurology, Klinikum LueneburgLüneburg, Lower Saxony, Germany
Department of Neurology, Ruhr-University of BochumBochum, North Rhine-Westphalia, Germany
Department of Neurology, Klinikum Essen-BorbeckEssen, North Rhine-Westphalia, Germany
Department of Neurology, Klinik AmbrockHagen, North Rhine-Westphalia, Germany
Department of Neurology, University of HomburgHomburg, Saarland, Germany
Department of Neurology, Technical University of DresdenDresden, Saxony, Germany
Department of Neurology, Charite BerlinBerlin, State of Berlin, Germany